Frontiers in Medicine (Mar 2022)

Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management?

  • Katharina Hüfner,
  • Piotr Tymoszuk,
  • Piotr Tymoszuk,
  • Dietmar Ausserhofer,
  • Sabina Sahanic,
  • Alex Pizzini,
  • Verena Rass,
  • Matyas Galffy,
  • Anna Böhm,
  • Katharina Kurz,
  • Thomas Sonnweber,
  • Ivan Tancevski,
  • Stefan Kiechl,
  • Andreas Huber,
  • Barbara Plagg,
  • Christian J. Wiedermann,
  • Rosa Bellmann-Weiler,
  • Herbert Bachler,
  • Günter Weiss,
  • Giuliano Piccoliori,
  • Raimund Helbok,
  • Judith Loeffler-Ragg,
  • Barbara Sperner-Unterweger

DOI
https://doi.org/10.3389/fmed.2022.792881
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundCoronavirus Disease-19 (COVID-19) convalescents are at risk of developing a de novo mental health disorder or worsening of a pre-existing one. COVID-19 outpatients have been less well characterized than their hospitalized counterparts. The objectives of our study were to identify indicators for poor mental health following COVID-19 outpatient management and to identify high-risk individuals.MethodsWe conducted a binational online survey study with adult non-hospitalized COVID-19 convalescents (Austria/AT: n = 1,157, Italy/IT: n = 893). Primary endpoints were positive screening for depression and anxiety (Patient Health Questionnaire; PHQ-4) and self-perceived overall mental health (OMH) and quality of life (QoL) rated with 4 point Likert scales. Psychosocial stress was surveyed with a modified PHQ stress module. Associations of the mental health and QoL with socio-demographic, COVID-19 course, and recovery variables were assessed by multi-parameter Random Forest and Poisson modeling. Mental health risk subsets were defined by self-organizing maps (SOMs) and hierarchical clustering algorithms. The survey analyses are publicly available (https://im2-ibk.shinyapps.io/mental_health_dashboard/).ResultsDepression and/or anxiety before infection was reported by 4.6% (IT)/6% (AT) of participants. At a median of 79 days (AT)/96 days (IT) post-COVID-19 onset, 12.4% (AT)/19.3% (IT) of subjects were screened positive for anxiety and 17.3% (AT)/23.2% (IT) for depression. Over one-fifth of the respondents rated their OMH (AT: 21.8%, IT: 24.1%) or QoL (AT: 20.3%, IT: 25.9%) as fair or poor. Psychosocial stress, physical performance loss, high numbers of acute and sub-acute COVID-19 complaints, and the presence of acute and sub-acute neurocognitive symptoms (impaired concentration, confusion, and forgetfulness) were the strongest correlates of deteriorating mental health and poor QoL. In clustering analysis, these variables defined subsets with a particularly high propensity of post-COVID-19 mental health impairment and decreased QoL. Pre-existing depression or anxiety (DA) was associated with an increased symptom burden during acute COVID-19 and recovery.ConclusionOur study revealed a bidirectional relationship between COVID-19 symptoms and mental health. We put forward specific acute symptoms of the disease as “red flags” of mental health deterioration, which should prompt general practitioners to identify non-hospitalized COVID-19 patients who may benefit from early psychological and psychiatric intervention.Clinical Trial Registration[ClinicalTrials.gov], identifier [NCT04661462].

Keywords